Leadership Board of Directors Our Culture In Memoriam
Our Approach Scientific Publications
Pipeline Our Programs Expanded Access
OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION SEC FILINGS CORPORATE GOVERNANCE EMAIL ALERTS

LEADERSHIP
TEAM

Our leadership team and board of directors are all drug hunters and developers with deep experience advancing successful commercial therapies and rational combination regimens.

 
leadership-team-1.jpg

Amy Burroughs
Chief Executive Officer

Scott Harris
Chief Development Officer

Melita Sun Jung
Chief Business Officer

Elona Kogan
Chief Legal Officer

Emil Kuriakose, M.D.
Chief Medical Officer

Jeff Jasper, Ph.D.
SVP, Research

James Kanter
SVP, CMC

Debra Sieminski
SVP, Medical Affairs

Rebecca Begley, Ph.D.
VP, Program and Alliance Management

David Strauss
VP, Finance and Controller

 
 
darkblue.jpg